MTOR and triple-negative breast carcinoma: This discrepancy may be attributed to varying expression levels of AGK protein in these two cell lines (Figure S1B) or could be associated with the heightened activation of the PI3K/AKT/mTOR signaling pathway in triple-negative breast cancer [30,31].